Dr. Stanley Crittenden has an unwavering focus on clinical excellence and is deeply passionate about doing his part in improving the healthcare system for all. As chief medical officer for Quantum Health, Dr. Crittenden is responsible for Quantum Health’s Clinical Strategy including Utilization Management, Pharmacy and Clinical Programs, enhancing Quantum Health’s existing clinical operations and strategy along with its growing its value-based care programs and clinical focus.

Prior to arriving at Quantum Health in 2024, Dr. Crittenden served as Chief Medical officer for Evergreen Nephrology, a Rubicon Founders portfolio company. During his time there, he led the creation of their payor and provider-integrated value-based care delivery model and supporting technology stack. As an expert in value-based care models, he also had responsibility for clinical product development and led the service teams responsible for utilization management, case management, health equity programs and business development. Before Evergreen, Dr. Crittenden served in physician executive roles with both Anthem and Humana where he was able to translate his direct patient care experience to create programs that delivered improved health outcomes, in both commercial and Medicare Advantage service lines. Prior to his population health, managed care and physician leadership journey, he was a practicing physician and Assistant Professor of Medicine at the Boston University Medical Center. Dr. Crittenden attended both undergraduate and medical school at Tulane University. He completed his residency in internal medicine at The University of Chicago and fellowship in nephrology at Weill Cornell Medical College and is board-certified in internal medicine and nephrology.  

Awards & recognition

  • Fellow of the American Society of Nephrology (FASN)
  • Humana Excellence and Leadership (HEAL) Award
  • Distinguished Fellow Housestaff Award, Weill Cornell Medical College Alumni Council/New York
  • Tulane 34 Award

Organizations

  • American Society of Nephrology
  • Partnership for Responsible Artificial/Augmented Intelligence (AI) in Kidney Health Steering Committee
  • Board Scientific Advisor, CorMedix, Inc

Education

  • Doctor of Medicine — Tulane University School of Medicine
  • Bachelor of Arts, Political Science — Tulane University
View leadership team
Stanley Crittenden